1E Therapeutics vs Immunai
1E Therapeutics vs Immunai, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 1E Therapeutics is on 48/100 and Immunai on 69/100.
Where each one leads
1E Therapeutics
- headcount growth: +18.6% against +13.0%
Immunai
- our overall score: 69/100 against 48/100
- domain rating: 46/100 against 20/100
- headcount: 179 against 49
- funding raised: $295M against $120M
- LinkedIn following: 26,832 against 3,258
At a glance
| Measure | 1E Therapeutics | Immunai |
|---|---|---|
| What it is | Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform. | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. |
| Category | Drug Development, Life Sciences, Therapeutics, RNA-Targeting | Healthcare, Immunology, Data, Analytics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2020 | 2019 |
| Headquarters | Not published | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | 1E Therapeutics | Immunai |
|---|---|---|
| Employees | 49 | 179 |
| Headcount growthLast 12 months | +18.6% | +13.0% |
| Total funding | $120M | $295M |
| Latest round | Seed | Series B |
| Valuation | Not published | $1.0B |
| LinkedIn followers | 3,258 | 26,832 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | 1E Therapeutics | Immunai |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 69/100 |
| Traction | 57/100 | 60/100 |
| Team | 50/100 | 70/100 |
| Search visibility | 39/100 | 39/100 |
| Quality | 45/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | 1E Therapeutics | Immunai |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
1E Therapeutics vs Immunai: common questions
Which is better, 1E Therapeutics or Immunai?
On our 0-100 score Immunai rates higher (69/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do 1E Therapeutics and Immunai compare on the numbers?
1E Therapeutics leads on headcount growth (+18.6% against +13.0%). Immunai leads on our overall score (69/100 against 48/100), domain rating (46/100 against 20/100), headcount (179 against 49), funding raised ($295M against $120M), LinkedIn following (26,832 against 3,258).
Read the full 1E Therapeutics review and pricing or the Immunai review and pricing. You can also browse other 1E Therapeutics alternatives we track.